CLINICAL_TRIALS
research
· 2022-04-29
Clinical Trial Update: Radio Guided Lymph Node Dissection in Oligometastatic Prostate Cancer Patients [Phase 1, Phase 2]
Summary
A clinical trial update on radio-guided lymph node dissection for oligometastatic prostate cancer, encompassing Phase 1 and Phase 2 stages.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Radboud University Medical Center | Conditions: Prostate Cancer, Lymph Node Metastases | Phase 1, Phase 2 | Status: UNKNOWN